Abstract
Background Breast cancer is a global concern, registering 2.3 million new cases and 685,000 deaths in 2020, with projections reaching 4.4 million cases by 2070. In Tanzania, it’s the second leading cause of cancer-related deaths among women, often diagnosed at advanced stages, leading to poor outcomes. Only 5% of women in the country report undergoing breast cancer screening, the aim study is to determine factors associated with breast cancer screening in Tanzania.
Methods A cross-sectional study among women of reproductive age in Tanzania, utilizing data from the Demographic and Health Surveys (DHS). We used available data on breast cancer screening the DHS. The outcome of the study was breast cancer screening. To find independent variables associated with breast cancer screening, logistic regression was used.
Results After controlling for other factors, the following factors remained significantly associated with breast cancer screening among women of reproductive age; age(AOR=5.33, 95% CI 3.72, 7.63), being wealthy (AOR=2.34, 95% CI 1.61, 3.38), residing in rural(AOR= 0.59, 95% CI 0.46, 0.763), being educated(AOR=2.43, 95% CI 1.60, 3.68), being insured(AOR= 2.40, 95% CI 1.89, 3.06), healthcare facility visits in the past 12 months(AOR=1.43, 95% CI 1.14, 1.78) and living in Northern zone(AOR= 2.43, 95% CI 1.42, 4.15) compared to western zone
Conclusion Breast cancer screening is still under-utilized and have shown to be marginalized in women of reproductive age. Policies to address disparities, comprehensive health education and awareness campaigns are instrumental to increase utilization and reduction of burden of breast cancers in Tanzania
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The formal written request was submitted to the DHS program and approval was given to access and utilize data from http://www.dhsprogram.com. The questionnaire for standard DHS was reviewed and approved Medical Research Council of Tanzania and the Zanzibar Health Research Institute and ICF’s Internal Review Board (IRB). Participants provided either written or verbal informed consent before participating in the survey.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
Data are not owned by the authors. Data are available from Tanzania Demographic and Health Surveys (DHS) program (https://dhsprogram.com/Data/). DHS data may be accessed through registration of a research project on the DHS website and requesting access to data. This is the same manner the authors obtained access to the data. The authors did not have any special access privileges to DHS data
